Clinical Trial Update: Post Marketing Observational Study on Paricalcitol IV Administered to Venezuelan Patients

View source ↗

Summary

A post-marketing observational study of intravenous paricalcitol in Venezuelan patients with chronic kidney disease on hemodialysis was terminated; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease Stage
• End-stage Renal Disease
• Hemodialysis

Drugs mentioned

• Paricalcitol IV (Paricalcitol)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Chronic Kidney Disease Stage V, Hemodialysis | Status: TERMINATED | Results posted: 2014-11-17